Hebrew University of Jerusalem Reports Findings in Drug Research (A retrospective cohort study of pediatric hospitalization due to dentoalveolar infection before and after a change in national health insurance): Drug Research

2022 DEC 12 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily -- New research on Drug Research is the subject of a report. According to news reporting out of Jerusalem, Israel, by NewsRx editors, research stated, “This retrospective cohort study aimed to examine trends in pediatric (0-18 years old) hospitalizations due to dentoalveolar infection, before and after the inclusion of pediatric dental care in Israel’s National Health Insurance Law. Data were collected from the medical records of one oral and maxillofacial surgery department.”

Our news journalists obtained a quote from the research from the Hebrew University of Jerusalem, “Data were compared between patients hospitalized during 2002-2010 (group A, n = 531) and 2011-2019 (group B, n = 381). The mean age of the cohort was 8 years. A dentoalveolar abscess was the main cause of hospitalizations in both groups. Group B exhibited a higher rate of previous dental treatment in general (p = 0.001), and of previous dental treatment for the tooth responsible for the infection (p = 0.03). The prevalent treatment during hospitalization combined intravenous antibiotics and extraction, with or without drainage (58.1%) for group A; and intravenous antibiotics and drainage (49.4%) for group B (p < 0.01).”

According to the news editors, the research concluded: “Dental care provided by the Israel’s National Health Insurance should focus not only on operative treatment but also on oral health promotion and caries prevention, to reduce hospitalizations due to dentoalveolar infections.”

For more information on this research see: A retrospective cohort study of pediatric hospitalization due to dentoalveolar infection before and after a change in national health insurance. Scientific Reports, 2022;12(1):20502. Scientific Reports can be contacted at: Nature Portfolio, Heidelberger Platz 3, Berlin, 14197, Germany. (Nature Publishing Group - http://www.nature.com/; Scientific Reports - http://www.nature.com/srep/)

Our news journalists report that additional information may be obtained by contacting Sahar Abdulqader, Faculty of Dental Medicine, Hebrew University of Jerusalem, P.O. Box 12272, 9112102, Jerusalem, Israel. Additional authors for this research include Itai Zeevi, Uri Zilberman, Moti Moskovitz and Avia Fux-Noy.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1038/s41598-022-25045-0. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Publisher contact information for the journal Scientific Reports is: Nature Portfolio, Heidelberger Platz 3, Berlin, 14197, Germany.

(Our reports deliver fact-based news of research and discoveries from around the world.)